Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Torriani

Showing results (191-200 of 195) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 195 results.
JCI Insight|July 24, 2020
Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLDLindsay T Fourman, James M Billingsley, George Agyapong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2021
Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver DiseaseTakara L Stanley, Lindsay T Fourman, Lai Ping Wong, et al.
The Lancet. HIV|October 16, 2019
Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trialTakara L Stanley, Lindsay T Fourman, Meghan N Feldpausch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2023
Randomized Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Myocardial Perfusion and Function Among Persons With Human Immunodeficiency Virus (HIV)-Results From the MIRACLE HIV StudySuman Srinivasa, Allie R Walpert, Teressa S Thomas, et al.
NEJM Evidence|May 30, 2024
Intranasal Oxytocin for ObesityFranziska Plessow, Liya Kerem, Marie-Louis Wronski, et al.
Pageof 20

Showing results (191-200 of 195) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 195 results.
JCI Insight|July 24, 2020
Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLDLindsay T Fourman, James M Billingsley, George Agyapong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2021
Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver DiseaseTakara L Stanley, Lindsay T Fourman, Lai Ping Wong, et al.
The Lancet. HIV|October 16, 2019
Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trialTakara L Stanley, Lindsay T Fourman, Meghan N Feldpausch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2023
Randomized Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Myocardial Perfusion and Function Among Persons With Human Immunodeficiency Virus (HIV)-Results From the MIRACLE HIV StudySuman Srinivasa, Allie R Walpert, Teressa S Thomas, et al.
NEJM Evidence|May 30, 2024
Intranasal Oxytocin for ObesityFranziska Plessow, Liya Kerem, Marie-Louis Wronski, et al.
Pageof 20